A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

Paraganglioma Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Global Panuvei ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely ...

A new medical database automatically compiles the medical records of obese patients and those suffering from obesity-related diseases in a uniquely comprehensive and reliable manner. The initiative, ...

Advancement of AbbVie Inc. and OSE Immunotherapeutics strategic partnership to develop ABBV-230: in April 2024, the Hart-Scott-Rodino waiting period expired enabling teams to commence work around the ...

Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...

AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline ...

Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by ...

DALLAS Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics ...